Countries Australia

Australia's Qbiotics concludes successful $85 million capital raise

Capital raise nets $85 million from Existing Shareholders, Existing Institutional Investors, and cornerstone investor TDM Growth Partners. Fun...

 June 28, 2021 | News

Australia's Viraleze™ is highly effective against Alpha, Beta and Gamma COVID variants

The results from the renowned Scripps Research Institute in the US confirm that SPL7013, the active ingredient in Viraleze™, is highly acti...

 June 18, 2021 | News

ENA Respiratory secured up to AU$32m investment to Advances COVID-19 Preventative Therapy

Round jointly led by Brandon Capital and Minderoo Foundation with co-investment from Uniseed will support the clinical development of INNA-051 Company a...

 June 16, 2021 | News

Sermo Acquires Minter Group to connect the pharmaceutical industry In APAC

Sermo, the world’s leading HCP insights company and the first social media platform for physicians, today announced its acquisition of Australia-base...

 June 15, 2021 | News

Viraleze registered for sale in Covid-ravaged India

The announcement came as the world's second most populous country battles a devastating second wave of COVID-19 infections, with over 29 million cases and ...

 June 14, 2021 | News

Theramex UK Ltd announces a license and supply agreement with Enzene Biosciences Limited

Theramex UK Ltd announces a license and supply agreement with Enzene Biosciences Limited, for the registration and commercialisation of denosumab, an antir...

 June 10, 2021 | News

Australian researchers lead world in successful trial of new cancer treatment

Relatlimab is the first immunotherapy treatment to target LAG-3, a protein in immune cells which reinvigorates and enhances the tumour fighting r...

 June 07, 2021 | News

21% were not aware Australian data is accepted by the FDA and other major regulatory authorities

The leading Australian CRO for biotechs and Frost & Sullivan Asia-Pacific CRO Market Leadership Award recipient Avance Clinical announced the results o...

 June 04, 2021 | Analysis

Illumina and Next Generation Genomic Partner to Launch VeriSeq™ NIPT Solution in Thailand

llumina, Inc., the global leader in DNA sequencing and array-based technologies and Next Generation Genomic Co., Ltd. (NGG Thailand), the Association of So...

 June 01, 2021 | News

BioFactura Announces Initiation of Phase I Study of BFI-751, a Stelara® Biosimilar

First clinical trial from BioFactura’s pipeline of high-value biosimilar and biodefense drugs BFI-751: Biosimilar designed to treat people with Cr...

 June 01, 2021 | News

World-first multiple sclerosis global image database launched

A world-first global MS image database launched in Australia today complementing MSBase, the largest clinical MS patient registry, to advance MS research w...

 May 31, 2021 | News

Avance Clinical Releases Industry Survey Results at BIO Korea 2021

The leading Australian CRO for biotechs and Frost & Sullivan Asia-Pacific CRO Market Leadership Award recipient Avance Clinical shared results of a rec...

 May 27, 2021 | News

Multiply Labs Joins forces with Cytiva to automate cell therapy manufacturing.

  Creating a fully automated robotic system will bring industrial scale reliability to cell therapy manufacturing while providing speed and flexibi...

 May 26, 2021 | News

Top 3 COVID-19 vaccine questions : Vaccine choice, appointments and blood clots

  Intended audience:  General public             Top 3 questions Why can’t I decide which vac...

 May 25, 2021 | Opinion


Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close